CN101407837B - Gene chip for detecting blood pathogen and reagent kit for detecting - Google Patents

Gene chip for detecting blood pathogen and reagent kit for detecting Download PDF

Info

Publication number
CN101407837B
CN101407837B CN2007101640062A CN200710164006A CN101407837B CN 101407837 B CN101407837 B CN 101407837B CN 2007101640062 A CN2007101640062 A CN 2007101640062A CN 200710164006 A CN200710164006 A CN 200710164006A CN 101407837 B CN101407837 B CN 101407837B
Authority
CN
China
Prior art keywords
gene chip
probe
seq
blood
gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2007101640062A
Other languages
Chinese (zh)
Other versions
CN101407837A (en
Inventor
王磊
韩巍青
曹勃阳
冯露
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tianjin Biochip Corp
Original Assignee
Tianjin Biochip Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tianjin Biochip Corp filed Critical Tianjin Biochip Corp
Priority to CN2007101640062A priority Critical patent/CN101407837B/en
Publication of CN101407837A publication Critical patent/CN101407837A/en
Application granted granted Critical
Publication of CN101407837B publication Critical patent/CN101407837B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The invention relates to a gene chip used for detecting blood pathogen and a kit used for detection. The gene chip includes a solid phase vector and an oligonucleotide probe fixed on the solid phase vector, wherein the oligonucleotide probe mainly comprises DNA segments selected from the 16S rRNA gene sequence and the nuc gene sequence of one or a plurality of blood pathogen. The kit includes the gene chip. The gene chip can be used for cross-breeding and detecting the pathogen in the blood according to a cross-breeding signal. The gene chip can be utilized to achieve the goal of detecting the blood pathogen, is simple to be operated, is high in accuracy and is strong in repetitiveness, can give out a detection result in 24 hours and has certain directive significance to the medicating of clinic doctors.

Description

Be used for gene chip and detection test kit that blood pathogen detects
Technical field
The present invention relates to a kind of gene chip and test kit, relate in particular to a kind of gene chip and test kit that blood pathogen detects that be used for.
Background technology
Healthy people's blood is aseptic, when body local infects when whole body is sent out and the systemic infection symptom occurs, occurs bacterium in the blood, can be divided into microbemia, septicemia and toxicaemia by the degree difference.Wherein the clinical symptom with septicemia is the most serious.Microbemia is from the propagation of pathogeny microorganism at infection site, subsequently in position propagation or with blood propagation, cause microbemia, discharge constituent lipopolysaccharides (or intracellular toxin), peptidoglycolipid, lipoteichoicacid, perienzyme of a large amount of microorganisms etc. simultaneously, and then induce the release of autogenous infection medium.Cause the release of inflammatory mediator such as cytokine, arachidonic acid metabolite, lectin, complement, nitrogen protoxide, endorphin, cytokinin to increase, and induce other important physical effects, even cause multiple organ dysfunction syndrome (MOF) death.Septicemia is meant pathogenic bacterium intrusion blood circulation, continues to exist, and breeding produces a large amount of toxin rapidly, causes serious constitutional symptom.Generally taking place in patient's whole body situation difference with under the situation that toxicity of pathogenic bacteria is big, quantity is many, is a kind of serious situation.Septicemia causes by a kind of pathogenic bacteria usually, but also has the pathogenic bacteria by two or more kinds to be caused, is called plural bacterium septicemia, and in whole septicemia, its sickness rate surpasses 10%.The prognosis of septicemia is than disease, and mortality ratio is generally 30~50%; The mortality ratio of plural number bacterium septicemia is higher, can reach 70%~80%.
The 10 class blood pathogens that China is common comprise streptococcus aureus, coagulase negative staphylococcus, streptococcus, Pseudomonas aeruginosa, serratia marcescens, klebsiella/enterobacteria (Klebsiella pneumonia, acid-producing Klebsiella bacterium; Enterobacter cloacae, enteroaerogen), intestinal bacteria, faecium, enterococcus faecalis, citrobacter freundii.
Existing advanced clinical microbemia checking system has two classes: " hemoculture detection and analytical system automatically " and " the digital classification of microorganism identification systems (API) ".These the two kinds systems that extensively adopted by hospital need biochemical identification or serological reaction after all tested sample being increased the bacterium cultivation, need 3 to 5 days usually.Maximum drawback is that required time is longer, and the abuse of Broad spectrum antibiotics causes clinical diagnosis complicated before this, can not meet clinical needs, and this often makes the clinician miss best treatment opportunity.And biochip is owing to have high-throughout characteristics, can determine the various bacteria kind that contains on the chip by single test, thereby avoid waste of time, and shortened the time of microbemia check, the clinician is effectively executed tool important directive significance.
Since nineteen nineties, biochip technology has been set up as a kind of brand-new analysis and detection technology, and along with carrying out progressively of the Human Genome Project grows up.This technological synthesis has used Protocols in Molecular Biology, ic manufacturing technology, computer technology, semiconductor technology, confocal laser scanning technique, fluorescent mark technology to make testing process have characteristics such as susceptibility height, high specificity, large scale integration, automatization, simple and efficient to handle, efficient height, is subjected to scientific research personnel's favor.At present biochip technology has been widely applied to the numerous areas such as prevention, diagnosis and treatment, new drug development, environmental pollution monitoring of molecular biology, disease.
As everyone knows, the sequence of the 16S rRNA gene in the prokaryote is very conservative, be not subjected to microorganism envrionment conditions of living in variation, nutritive substance rich scarce influence and change to some extent, can see the time ruler of organic evolution as, writing down the true vestige of organic evolution.The 16S rRNA gene of bacterium has suitable variability, thereby shows polytypism on sequence, has been widely used in the evaluation of bacterium Evolution analysis and kind.Therefore, the base sequence of the 16S rRNA gene in the analyzing prokaryote cell, the homology of 16S rRNA gene order between the microorganism that comparison is analyzed and other microbial species, distance and the phylogeny status that can disclose their sibships truly.Think that according to the life tree that the 16SrRNA gene is set up life is by bacterium territory (Bacteria), ancient bacterium territory (Archaea) and eukaryote territory (Eucarya) formation.Sequence similarity<60% between three territory biologies, similarity in the territory>70%, sequence similarity of the same race>97%.16S rRNA gene order changes slowly, crosses over whole life evolutionary process, contains the rate of evolution different zones in the molecule, can be used as the basis of classification.
In sum, be necessary to invent a kind of biochip technology product and method thereof quick, accurate, that reliably blood pathogen is detected utilized.
Summary of the invention
In view of the foregoing, an object of the present invention is to provide a kind of gene chip that blood pathogen detects that is used for, to remedy the deficiency that traditional blood pathogen detection technique exists, it is quick, accurate and reliable to realize that blood pathogen detects.
Another object of the present invention provides a kind of test kit that is used to detect blood pathogen that comprises the said gene chip at least.
A further object of the present invention provides the method for utilizing described gene chip and test kit to come fast, detect accurately, delicately blood pathogen.
For achieving the above object, the present invention has adopted following technical scheme:
The invention provides a kind of gene chip that blood pathogen detects that is used for, comprise solid phase carrier and the oligonucleotide probe that is fixed on this solid phase carrier, wherein said oligonucleotide probe comprises the dna fragmentation of choosing from the 16S rRNA gene order of a class or a few class blood pathogens and nuc gene order.
Described dna fragmentation is at least a of SEQ ID NO:1-SEQ ID NO:28.
In the preferred embodiment of the present invention, described oligonucleotide probe also comprises positive control probe, negative control probe and fluorescent probe.
In the preferred embodiment of the present invention, described fluorescent probe has the nucleotide sequence of SEQ ID NO:29; Negative control probe has the nucleotide sequence of SEQ ID NO:30; The positive control probe has the nucleotide sequence of SEQ ID NO:31.
Class described in the present invention or a few class blood pathogen are selected from streptococcus aureus, coagulase negative staphylococcus, streptococcus, Pseudomonas aeruginosa, serratia marcescens, klebsiella/enterobacteria, intestinal bacteria, faecium, enterococcus faecalis, citrobacter freundii.
Wherein said klebsiella/enterobacteria comprises Klebsiella pneumonia, acid-producing Klebsiella bacterium, enterobacter cloacae, enteroaerogen.
Gene chip described in the present invention can be used at least a detection of streptococcus aureus, coagulase negative staphylococcus, streptococcus, Pseudomonas aeruginosa, serratia marcescens, klebsiella/enterobacteria, intestinal bacteria, faecium, enterococcus faecalis, citrobacter freundii blood pathogen, and wherein said klebsiella/enterobacteria comprises Klebsiella pneumonia, acid-producing Klebsiella bacterium, enterobacter cloacae, enteroaerogen.
Wherein the detection probes of Ying Yonging is at least a among the SEQ ID NO:32-SEQ ID NO:37.
The present invention also provides a kind of test kit that blood pathogen detects that is used for, and this this test kit comprises gene chip of the present invention.
Test kit of the present invention also comprises detection probes at least a of SEQ ID NO:32-SEQ ID NO:37.
Test kit of the present invention can also comprise interpretation software and specification sheets that hybridizing box, hybridization solution and Analysis and Identification result use.
Test kit of the present invention can be used at least a detection of streptococcus aureus, coagulase negative staphylococcus, streptococcus, Pseudomonas aeruginosa, serratia marcescens, klebsiella/enterobacteria, intestinal bacteria, faecium, enterococcus faecalis, citrobacter freundii blood pathogen, and wherein said klebsiella/enterobacteria comprises Klebsiella pneumonia, acid-producing Klebsiella bacterium, enterobacter cloacae, enteroaerogen.
The present invention also proposes to use the method for described gene chip and test kit detection blood pathogen, may further comprise the steps:
(1) zone design suitable according to 16S rRNA gene order both sides and high conservative the universal primer of 16S rRNA gene order that is used to increase;
(2) prepare the genomic dna of testing sample according to a conventional method, use primer in the step (1) to treat test sample product genomic dna and carry out the target sequence that pcr amplification and purifying increase and obtain;
(3) target sequence that obtains in the markers step (2);
(4) with target sequence behind the mark and said gene chip hybridization;
(5) obtain hybridization signal and Analysis and Identification results of hybridization with biochip scanner.
In preferred embodiment of the present invention, the upstream primer sequence of the zone design of suitable according to 16S rRNA gene order both sides to high conservative is SEQ ID NO:32-33 in the above-mentioned steps (1), and the downstream primer sequence is SEQ ID NO:34-SEQ ID NO:37.
In preferred embodiment of the present invention, use interpretation software BactarrayAnalyzer Analysis and Identification results of hybridization in the above-mentioned steps (5).
As seen from the above technical solutions, utilize gene chip of the present invention to reach to detect and the purpose of definite blood infection patient institute bacterial infection kind, because it is easy and simple to handle, the accuracy height, repeatability is strong, in 24 hours, can provide detected result, certain directive significance be arranged for clinician's medication.
For above and other objects of the present invention, feature and advantage can be become apparent, below especially exemplified by preferred embodiment, and cooperate Figure of description, be described in detail below.
Description of drawings
Fig. 1 is the profile synoptic diagram of the gene chip of one embodiment of the invention.
Fig. 2 is the synoptic diagram of arranging of probe on the embodiment of gene chip of the present invention.
Fig. 3 A-Fig. 3 J is for carrying out the hybridization scanning result of sample detection with an embodiment of gene chip of the present invention.
Fig. 4 A-Fig. 4 B saves as the process synoptic diagram of .gpr file for the hybridization scanning result that an embodiment of gene chip of the present invention is carried out sample detection.
Fig. 5 is an analysis result information that embodiment detects that utilizes gene chip of the present invention.
Fig. 6 is the evolutionary tree of 64 kinds of bacterial 16 S rRNA genic systems.
Embodiment
For further specifying gene chip and the detection method thereof that blood pathogen detects that be used for of the present invention, describe especially exemplified by following preferred embodiment, these embodiment are in order to illustrate rather than limit by any way the present invention.
Embodiment one: the design of probe and preparation
1. sequence obtains
From GenBank, download the 16S rRNA gene order that obtains above-mentioned 10 class blood pathogens.
2. probe design
Compare all download sequence with Clustal X software,,, design 75 of the oligonucleotide probes of above-mentioned 10 class blood pathogens altogether at the probe of the region of variability of 16S rRNA gene order design at each bacterioid according to comparison result.
3. probe screening
Carry out the probe screening by 766 hybrid experiments, finally obtain 31 suitable probes, comprise 28 specific probes at blood pathogen, 1 positive control probe, 1 negative control probe and fluorescent probe, its base sequence is shown in following table 1, table 2.
Wherein, 28 probes (SEQ ID NO:1-NO:28) that are numbered NO.1-NO.28 are selected from the 16S rRNA gene order of streptococcus aureus in the blood common pathogen, streptococcus, coagulase negative staphylococcus, Pseudomonas aeruginosa, serratia marcescens, klebsiella/enterobacteria, intestinal bacteria, faecium, enterococcus faecalis, citrobacter freundii respectively, and these probes can detect corresponding source strain respectively from test sample.The quality of glass chip is monitored and the probe location on the scanning result figure is positioned with the poly T sequence that has fluorescent mark Cy3., be used for non-specific hybridization situation is monitored as negative control probe with the probe that contains a plurality of T.The probe that is numbered NO.31 is used for test sample and whether contains bacterium as the positive control probe.
Selected probe sequence and relevant detection bacterium among table 1. gene chip one embodiment of the present invention
SEQID The probe numbering Source (being selected from the nuc gene order of streptococcus aureus respectively) Probe sequence (5 '-3 ') Detect bacterium
NO:1 ?NO.1 Streptococcus aureus AACGGACGAGAAGCTTGCTTCTCT Streptococcus aureus
NO:2 ?NO.2 Streptococcus aureus GATACACCTGAAACAAAGCATCC Streptococcus aureus
NO:3 ?NO.3 Streptococcus aureus GTGTAGAGAAATATGGTCCTGA Streptococcus aureus
Selected probe sequence and relevant detection bacterium (continuing) among table 2. gene chip one embodiment of the present invention
SEQID The probe numbering Source (being selected from the 16SrRNA gene order of following bacterium respectively) Probe sequence (5 '-3 ') Detect bacterium
NO:4 NO.4 Streptococcus aureus GACAAAGGTCAAAGAACTGAT Streptococcus aureus
NO:5 ?NO.5 Streptococcus pneumoniae GTTAGACCCTTTCCGGGGTTTA Streptococcus pneumoniae
NO:6 ?NO.6 Streptococcus pneumoniae AAGAGTAGATGTTGCATGACATTT Streptococcus pneumoniae
NO:7 ?NO.7 Streptococcus pneumoniae GTGAGAGTGGAAAGTTCACACTG Streptococcus pneumoniae
NO:8 ?NO.8 Coagulase negative staphylococcus/streptococcus aureus CCTACCTATAAGACTGGGATAA Coagulase negative staphylococcus
NO:9 ?NO.9 Coagulase negative staphylococcus/streptococcus aureus AACTTCGGGAAACCGGAGCT Coagulase negative staphylococcus/streptococcus aureus
NO:10 ?NO.10 Coagulase negative staphylococcus/streptococcus aureus GTCACTTATAGATGGACCCG Coagulase negative staphylococcus/streptococcus aureus
NO:11 ?NO.11 Pseudomonas aeruginosa CATACGTCCTGAGGGAGAAAGTG Pseudomonas aeruginosa
NO:12 ?NO.12 Pseudomonas aeruginosa GGGCAGTAAGTTAATACCTTGCTGT Pseudomonas aeruginosa
NO:13 ?NO.13 Pseudomonas aeruginosa ATGAAGGGAGCTTGCTCCTGGAT Pseudomonas aeruginosa
NO:14 ?NO.14 Pseudomonas aeruginosa CCGTTGGGATCCTTGAGATC Pseudomonas aeruginosa
NO:15 ?NO.15 Serratia marcescens ACGCTCATCAATTGACGTTACT Serratia marcescens
NO:16 ?NO.16 Serratia marcescens/citrobacter freundii GCACAGGGGAGCTTGCTCCCTGG Serratia marcescens/citrobacter freundii
NO:17 ?NO.17 Serratia marcescens GGTGGTGAACTTAATACGTTCATCA Serratia marcescens
NO:18 ?NO.18 Klebsiella/enterobacteria GGCGATAAGGTTAATAACCTTGTCG Klebsiella/enterobacteria
NO:19 ?NO.19 Klebsiella/enterobacteria/citrobacter freundii AGCACAGAGAGCTTGCTCTCGG Klebsiella/enterobacteria/citrobacter freundii
NO:20 ?NO.20 Klebsiella/enterobacteria/serratia marcescens/intestinal bacteria/citrobacter freundii CAAAGTGGGGGACCTTCGGGCCTC Klebsiella/enterobacteria/serratia marcescens/intestinal bacteria/citrobacter freundii
NO:21 ?NO.21 Intestinal bacteria/serratia marcescens/Cray primary/enterobacteria/citrobacter freundii GCCATCGGATGTGCCCA Intestinal bacteria/serratia marcescens/Cray primary/enterobacteria/citrobacter freundii
NO:22 ?NO.22 Intestinal bacteria AGGGAGTAAAGTTAATACCTTTGCTC Intestinal bacteria
NO:23 ?NO.23 Intestinal bacteria CAGGAAACAGCTTGCTG Intestinal bacteria
TTTCGC
NO:24 ?NO.24 Intestinal bacteria CAGGAAGAAGCTTGCTTCTTTGC Intestinal bacteria
NO:25 ?NO.25 Faecium ATGAGAGTAACTGTTCATCCCTTG Faecium
NO:26 ?NO.26 Faecium CAAAACCGCATGGTTTTGATTTG Faecium
NO:27 ?NO.27 Enterococcus faecalis ACGTTAGTAACTGAACGTCCCCTG Enterococcus faecalis
NO:28 ?NO.28 Enterococcus faecalis ATGCCGCATGGCATAAGAGTG Enterococcus faecalis
NO:29 ?NO.29 Fluorescent probe TTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT-Cy3 Contrast as fluorescence
NO:30 ?NO.30 Negative control probe TTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT As negative control
NO:31 ?NO.31 The positive control probe ACTCCTACGGGAGGCAGC As positive control
4. probe is synthetic
According to the sequence synthesising probing needle in the table 1, carry out poly (T) and amido modified at 5 ' end.
Embodiment two: primer design and preparation
Utilize the interior sequence resources of public databases such as information biology software analysis GenBank such as Primer 5.0, the zone design of suitable high conservative in 16S rRNA gene order both sides 2 of the universal primers of the 16S rRNA gene order that is used to increase, this primer sequence and uses thereof is as shown in table 2 below.
Table 3.16S rRNA gene amplification universal primer and purposes
The primer numbering Primer sequence (5 '-3 ') The primer purposes
1 5 '-AGAGTTTGATCATGGCTCAG-3 ' (SEQ ID NO:32) and 5 '-AGAGTTTGATCCTGGCTCAG-3 ' (SEQ ID NO:33) The 16S upstream primer
2 5 '-CCGTCAATTCATTTAAGTTT-3 ' (SEQ ID NO:34), 5 '-CCGTCAATTCATTTGAGTTT-3 ' (SEQ ID NO:35), 5 '-CCGTCAATTCCTTTAAGTTT-3 ' (SEQ ID NO:36) and 5 '-CCGTCAATTCCTTTGAGTTT-3 ' (SEQ ID NO:37) The 16S downstream primer
Embodiment three: the preparation of gene chip
1. dissolving probe
Synthetic probe among the embodiment one is dissolved in the 50%DMSO solution, makes the final concentration of probe reach 1 μ g/ μ l.
2. point sample
Utilize automated biological chip point sample instrument (Spotarray 72) with probe points to slide, form the microarray design.As shown in Figure 1, the chip that uses in the present embodiment is to be solid phase carrier with 57.5mm * 25.5mm * 1mm (length * wide * height) through the slide of aldehyde radicalization, in the point sample district with 31 oligonucleotide probe points of synthetic among the embodiment one 3mm * 3mm on slide, low density DNA micromatrix in the formation, the array arrangement rule is identical in six point sample districts on the slide.As shown in Figure 2, the probe that has provided each point sample district is in detail arranged, and is the individual probe points in 9 (OK) * 12 (row) in each point sample district, and every probe repeats point sample 3 times, be numbered probe label in the table 1 in the bracket, the position that synopsis 1 can every probe of detail knowledge.
With the slide drying behind the point sample, UV-crosslinked, promptly obtain the gene chip that is used to detect the blood important pathogenic bacteria of preferred embodiment according to the present invention.
Embodiment four: utilize the pathogenic bacterium in the above-mentioned gene chip rapid detection blood for preparing
Utilizing the above-mentioned gene chip for preparing to detect in the method for blood pathogen, the present invention has all done a series of experiment to factors such as detection step, testing conditions and has groped, as each component proportions in the PCR reaction mixture, the PCR cycling condition, hybridization temperature, hybridization time etc. and main agents prescription are as hybridization solution, washing lotions etc. (prescription sees following examples for details) are the good ratio that obtains through after the gradient experiment.PCR cycling condition, especially annealing time and extension time is the good condition for selecting after the gradient experiment also.The blood important pathogenic bacteria detects the experiment flow of gene chip also for optimizing the back result.
In addition, the present invention use from clinical sample (positive or negative, promptly being that fully automatic blood is cultivated the positive or negative hemoculture thing after instrument is reported to the police) method of extracting bacterial genomes is the method (it is described to see following examples for details) of alkali cleaning/thermo-cracking, this method can be extracted bacterial genomes effectively from the hemoculture thing, be applicable to Gram-positive and gram negative bacterium.This method can also be eliminated in the hemoculture thing inhibitor to subsequent reactions (mainly being PCR), and has higher sensitivity.
Detection method of the present invention is: after extracting the testing sample genome, through the double-stranded amplification of PCR, the double-stranded PCR product of purifying, utilize downstream primer PCR strand mark, purification of single stranded PCR product, obtain marked product, marked product and hybridization solution are mixed the probe array FX that is added on the gene chip at 1: 1, and 50 ℃ of water-baths were hybridized 1.5 hours, after hybridization is finished, gene chip is washed by ionic strength order from high to low with the washing lotion for preparing, after air-dry, at 635nm, the 532nm wavelength is the scanning chip down, obtains the collection of illustrative plates and the data message of target sequence and chip hybridization, by computer software analysis, judge the kind of bacterial infection.
Below, be described in detail as follows for utilizing the above-mentioned gene chip for preparing to detect the preferred embodiment of blood pathogen:
1. the prehybridization of chip
(1) above-mentioned UV-crosslinked chip is put into the prehybridization solution of 42 ℃ of preheatings of 500ml, 42 ℃ left standstill 1 hour.
The prehybridization solution prescription: 1%BSA (bovine serum albumin) (W/V)
5 * SSC (sodium-chlor-sodium citrate solution)
0.1%SDS (sodium lauryl sulphate) (W/V)
(2) at ddH 2Carry among the O and wash ethanol dehydration in 1 minute twice, 95% 2 minutes, cold wind dries up, and is standby.
2. sample source
Positive: clinical collection patient venous blood 5ml injects Blood culture bottle, 35 ℃ of positive blood cultures of cultivating after certain hour to fully automatic blood is cultivated the instrument warning.(annotate: the positive in the research is from U.S. BD and French Mei Liai hemoculture instrument)
Negative sample: fully automatic blood is cultivated the negative hemoculture thing of instrument warning.
3. sample extraction
(1) getting 450 μ l clinical samples joins in the 1.5ml screw socket centrifuge tube.
(2) add 900 μ l sample extracting solution I (0.5M sodium hydroxide, 0.05M Trisodium Citrate), put upside down mixing repeatedly 10 minutes.
(3) 13, centrifugal 5 minutes of 000 * g topples over supernatant at once.
(4) precipitation is resuspended with 500 μ l sample extracting solution II (0.5MTris-HCl pH8.0).
(5) 13, centrifugal 5 minutes of 000 * g topples over supernatant at once.
(6) precipitation is resuspended with 500 μ l sample extracting solution II.
(7) 13, centrifugal 5 minutes of 000 * g abandons supernatant.
(8) precipitation is resuspended with 100 μ l sample extracting solution III (10mMTris-HCl pH8.0,1mM EDTA), and 100 ℃ were boiled 10 minutes.
(9) 13, centrifugal 15 minutes of 000 * g gets supernatant 60 μ l and transfers in the new 1.5ml sterilization centrifuge tube, carries out follow-up PCR reaction or-20 ℃ of storages.
4. increase and mark
(1) the double-stranded amplification of PCR
Get the extract 3 μ l that above-mentioned steps 3 obtains and join in the double-stranded amplification PCR reaction mixture, the prescription of double-stranded amplification PCR reaction mixture is as shown in table 3 below.
The double-stranded amplification of table 4 PCR reaction mixture prescription
Composition The source Concentration Application of sample amount (μ l)
The PCR damping fluid The precious biological rTaq in Dalian carries 10× 3
dATP Dalian is precious biological 100mM 0.024
dCTP Dalian is precious biological 100mM 0.024
dGTP Dalian is precious biological 100mM 0.024
dTTP Dalian is precious biological 100mM 0.016
dUTP The worker is given birth in Shanghai 100mM 0.008
The Taq enzyme Precious biological 5U/μl 0.4
DNase?I Dalian is precious biological 70U/μl 0.07
Primer 1 The worker is given birth in Shanghai 100μM 0.08
Primer 2 The worker is given birth in Shanghai 100μM 0.08
The UNG enzyme The worker is given birth in Shanghai 1U/μl 0.1
ddH2O Millipore - 23.174
Annotate: upward primer 1 and primer 2 are primer listed in the table 2 in the table.Reaction tubes is put into PCR instrument (Biometra), and the loop parameter of setting is as follows:
37 15 minutes
94 10 minutes
72 5 minutes
4 20 hours
(2) purifying of double-stranded PCR product
With the double-stranded PCR product that amplification in the above-mentioned steps (1) obtains, add in the purification column (MILLIPORE company), moisturizing to 400 μ l, 1,000 * g, centrifugal 15 minutes, abandon liquid, on the purification column film, add 30 μ l ddH 2O, 37 ℃ left standstill 5 minutes, purification column is tipped upside down on the new 1.5ml centrifuge tube, 1,000 * g, centrifugal 2 minutes, the solution of centrifugal gained was the purified product of double-stranded PCR.
(3) PCR strand mark
Get the double-stranded PCR purified product 10 μ l that obtain in the above-mentioned steps (2) and join in the strand mark PCR reaction mixture, the prescription of strand mark PCR reaction mixture is as shown in table 4 below.
Table 5: strand mark PCR reaction mixture prescription
Composition Concentration Application of sample amount (μ l)
The PCR damping fluid 10× 3
dATP 100mM 0.024
dCTP 100mM 0.024
dGTP 100mM 0.024
dTTP 100mM 0.016
dUTP 100mM 0.008
The Taq enzyme 5U/μl 0.4
DNase?I 70U/μl 0.07
Primer 2 100μM 0.08
Cy5-dCTP 1nmol/μl 0.3
ddH 2O - 16.054
Annotate: upward primer 2 is a primer listed in the table 2 in the table.
Reaction tubes is put into PCR instrument (Biometra), and the loop parameter of setting is as follows:
94 10 minutes
Figure S2007101640062D00131
72 5 minutes
4 20 hours
(4) obtain strand PCR product
5. hybridization
The preparation of hybridization reaction solution: the strand PCR product 8 μ l that above-mentioned steps 4 obtains, 2 * hybridization solution, the 8 μ l of 50 ℃ of preheatings mix, and centrifugal froth breaking is standby.
Getting the gene chip for preparing in the foregoing description three places in the hybridizing box (Bo Ao company), cover the cover plate (Bo Ao company) of customization, with the hybridization reaction solution point for preparing probe array zone at this chip, note between cover plate and the chip bubble being arranged, cover tight hybridizing box, put into 50 ℃ of water-bath 1.5h.After hybridizing end, take out hybridizing box, remove cover plate, washed 3 minutes in washing lotion A successively respectively, washed 3 minutes among the washing lotion B, washing is 1.5 minutes among the washing lotion C, and air-dry in air.
Hybridization solution prescription: 10% T 500 (dextran Sulfate); 25% methane amide (formamide); 0.1%SDS; 6 * SSPE
Washing lotion A:1 * SSC, 0.1%SDS
Washing lotion B:0.05 * SSC
Washing lotion C:95% ethanol
6. scanning
Use GenePix TMPersonal 4100A biochip scanner, operation Gene Pix Pro4.1 program is selected 635nm and 532nm two channels, and the PMT value transfers to 600, and scanning result saves as JPG, the file of TIF form.
Hybridization scanning result when test sample is above-mentioned 10 bacterioids respectively with the above-mentioned gene chip for preparing is shown in Fig. 3 A-Fig. 3 J.Wherein the sample represented respectively of Fig. 3 A-Fig. 3 J is: A, serratia marcescens, B, enterococcus faecalis, C, intestinal bacteria, D, streptococcus aureus, E, Cray Bai Shi Salmonella/enterobacteria, F, Pseudomonas aeruginosa, G, faecium, H, coagulase negative staphylococcus, I, streptococcus pneumoniae, J, citrobacter freundii.
Call the lasso file, obtain the fluorescence intensity level of each probe site, and the result is saved as the .gpr file, shown in Fig. 4 A and Fig. 4 B.
7. interpretation as a result
1. install and use interpretation software Bactarray Analyzer (by Tianjin Biochip Technology Co., Ltd's exploitation) as a result.
2. move Bactarray Analyzer program, and input user name, password.
3. the newly-built project of " new project " button on the click tools hurdle imports .gpr file to be analyzed by " importing file " then.Press Ctrl, can select and open a plurality of files simultaneously.
4. click " processing data " button, software will generate the log file of a treating processes automatically.Click filename at " listed files " page, the report page can automatically switch to the analysis result information of this document.Analysis result information is kept under the catalogue of this project place automatically.
5. interpretation as a result: as shown in Figure 5, report provides information such as censorship file name, sample number into spectrum, result, microorganism name, confidence level, score value, specific probe hybrid rate, fluorescence intensity, software interpretation date, software operation people.Wherein, " microorganism " item is detected bacterium name in the microbemia.
Embodiment five: gene chip is carried out specificity identify
Choose 64 kinds of comparatively common blood pathogens, utilized their 16S rRNA sequence construct systematic evolution tree.Systematic evolution tree can clearly show the evolutionary relationship between the various bacterial strains, and the residing evolution of the 10 bacterioids position that this chip detected.This analytical results that utilization obtains, we select for use with very approaching some bacteriums of target bacterium evolutionary relationship and carry out the specificity experiment.If can accurately distinguish these nearly edge bacteriums, illustrate that then probe has higher specificity, also just must distinguish the farther edge bacterium far away of other evolutionary relationship.
64 kinds of bacteriums of the structure evolutionary tree that present embodiment is selected for use comprise: 1 Acinetobactercalcoaceticus subsp.anitratus Acinetobacter calcoaceticus anitratum subspecies; 2Acinetobacter baumannii Acinetobacter baumannii; 3 Acinetobacter calcoaceticus Acinetobacter calcoaceticus; 4 Aerococcus viridans aerococcus viridanses; 5 Alcaligenes faecalis subsp.faecalis alcaligenes faecalis excrement subspecies; 6 Achromobacter xylosoxidans subsp.xylosoxidans Achromobacter xylosoxidans oxidation wood sugar subspecies; 7 Bacillus cereus Bacillus cereuss; 8 Bacillus subtilis subsp.subtilis Bacillus subtilus withered grass subspecies; 9 Bacteroidesfragilis bacteroides fragiliss; 10 Brucella melitensis biovar abortus Brucella melitensis miscarriage biotype; 11 Brucella melitensis Brucella melitensis; 12 Brucellamelitensis biovar neotomae Brucella melitensis wood mouse biotype; 13 Brucellamelitensis biovar Ovis Brucella melitensis sheep biotypes; 14 Corynebacteriumdiphtheriae corynebacterium diphtheriaes; 15 Citrobacter freundii citrobacter freundiis; 16Clostridium perfringens clostridium perfringens; 17 Enterobacter aerogenes enteroaerogen; 18 Pantoea agglomerans pantoea agglomerans; 19 Enterobacter cloacaesubsp.cloacae enterobacter cloacae cloaca subspecies; 20 Enterobacter hormaechei Huo Shi enterobacterias; 21 Enterococcus faecalis enterococcus faecalis; 22 Enterococcus faecium faeciums; 23 Enterococcus gallinarum Enterococcus gallinarums; 24 Escherichia coli intestinal bacteria; 25 Haemophilus influenzae hemophilus influenzaes; 26 Hafnia alvei hafnia alveis; 27 Klebsiella oxytoca acid-producing Klebsiella bacteriums; 28 Klebsiella pneumoniae Klebsiella pneumonia; 29 Listeria monocytogenes monokaryon hyperplasia listeria spps; 30 Micrococcusluteus micrococcus luteuses; 31 Mycobacterium tuberculosis mycobacterium tuberculosis; 32Neisseria gonorrhoeae Diplococcus gonorrhoeae; 33 Propionibacterium acnes CBPs; 34 Proteus mirabilis Proteus mirabilises; 35 Pseudomonas aeruginosa Pseudomonas aeruginosas; 36 Pseudomonas fluorescens Pseudomonas fluorescens; 37 Pseudomonasfluorescens Pseudomonas fluorescens; 38 Pseudomonas putida pseudomonas putidas; 39Pseudomonas stutzeri Pseudomonas stutzeri; 40 Streptococcus agalactiae streptococcus agalactiaes; 41 Streptococcus salivarius streptococcus-salivariuses; 42 Salmonella enterica subsp.enterica serovar Typhi salmonella typhis; 43 Salmonella enterica subsp.enterica enteron aisle Salmonellas sramana subspecies; 44 Serratia marcescens subsp.marcescens serratia marcescens cement subspecies; 45 Sphingobacterium multivorum Sphingobacterium multivorums; The golden yellow subspecies of 46Staphylococcus aureus subsp.aureus streptococcus aureus; 47Staphylococcus cohnii subsp.cohnii Staphylococcus cohnis Ke Shi subspecies; 48Staphylococcus epidermidis staphylococcus epidermidis; 49 Staphylococcus haemolyticus staphylococcus haemolyticuses; 50 Staphylococcus hominis subsp.hominis staphylococcus hominis people subspecies; 51 Staphylococcus intermedius Staphylococcus intermedius; The saprophytic subspecies of 52 Staphylococcussaprophyticus subsp.saprophyticus Staphylococcus saprophyticus; 53Staphylococcus sciuri subsp.sciuri Staphylococcus sciuri squirrel subspecies; 54Staphylococcus simulans imitates staphylococcus; 55 Staphylococcus xylosus staphylococcus xylosus; 56 Stenotrophomonas maltophilia stenotrophomonas maltophilias; 57Streptococcus oralis Streptococcus oralis; 58 Streptococcus pneumoniae streptococcus pneumoniaes; 59 Streptococcus pyogenes micrococcus scarlatinaes; 60 Tetragenococcus doogicus; 61 Tetragenococcus koreensis; 62 Aeromonas hydrophila subsp.hydrophila Aeromonas hydrophilas are had a liking for the water subspecies; The sense of 63 Moraxella (Branhamella) catarrhalis moraxelle catarrhalis; 64 Lactobaci llus acidophilus Lactobacterium acidophilums are specifically referring to Fig. 6.
By 449 hybrid experiments, prove that this chip can accurately distinguish: enterococcus faecalis, faecium and Enterococcus gallinarum (in the evolutionary tree position: 23,24,25) of homology between 95% to 95.5%; Homology is 97.4% streptococcus aureus and staphylococcus epidermidis (position in the evolutionary tree: 52 and 54); Homology is 92.1% streptococcus pneumoniae and streptococcus-salivarius (position in the evolutionary tree: 47 and 64); Homology is 93.0% Pseudomonas aeruginosa and Pseudomonas fluorescens (position in the evolutionary tree: 41 and 42); Intestinal bacteria between the homology 94% to 97.1%, Klebsiella pneumonia, serratia marcescens and Salmonellas (position in the evolutionary tree: 26,31,50,48 and 49).In addition, present embodiment also utilizes the bacterium of some edge far away, has carried out the specificity experiment as the inferior Salmonella of germ oligotrophy unit cell, acinetobacter calcoaceticus, Staphylococcus saprophyticus and honeycomb Hough Buddhist nun, all obtains good result.
This detection chip can be finished in 24 hours and detect 9 common class pathogenic bacterium of China.
Finish the clinical samples of bacterial infection patients in 647 example this chip detection scopes altogether from year January in March, 2005 to 2006, particular case sees the following form:
Finish routine number Traditional detection and chip detection be coincidence rate as a result The chip detection accuracy
647 74.65% 98.6%
Traditional detection and chip detection be coincidence rate as a result: be meant that routine number that traditional detection and chip detection meet accounts for the ratio of whole case load.For incongruent case, will carry out the 16S sequence verification.
Chip detection accuracy: after the 16SrDNA sequence verification, prove that the correct routine number of chip detection result accounts for the ratio of whole case load.
Though the present invention discloses as above with preferred embodiment; but be not in order to qualification the present invention, any person of ordinary skill in the field, without departing from the spirit and scope of the present invention; can do a little change and improvement, thus protection scope of the present invention when with claim the person of being defined be as the criterion.
Sequence table
<110〉Tianjin Biochip Technology Co., Ltd
<120〉be used for gene chip and the detection test kit that blood pathogen detects
<130>5P13002-CN
<160>37
<170>PatentIn?version?3.2
<210>1
<211>49
<212>DNA
<213〉be selected from the nuc gene order of streptococcus aureus
<400>1
tttttttttt?tttttttttt?tttttaacgg?acgagaagct?tgcttctct 49
<210>2
<211>49
<212>DNA
<213〉be selected from the nuc gene order of streptococcus aureus
<400>2
tttttttttt?tttttttttt?ttttttgata?cacctgaaac?aaagcatcc 49
<210>3
<211>49
<212>DNA
<213〉be selected from the nuc gene order of streptococcus aureus
<400>3
tttttttttt?tttttttttt?tttttttgtg?tagagaaata?tggtcctga 49
<210>4
<211>49
<212>DNA
<213〉be selected from the 16SrRNA gene order of streptococcus aureus
<400>4
tttttttttt?tttttttttt?ttttttttga?caaaggtcaa?agaactgat 49
<210>5
<211>49
<212>DNA
<213〉be selected from the 16SrRNA gene order of streptococcus pneumoniae
<400>5
tttttttttt?tttttttttt?tttttttgtt?agaccctttc?cggggttta 49
<210>6
<211>49
<212>DNA
<213〉be selected from the 16SrRNA gene order of streptococcus pneumoniae
<400>6
tttttttttt?tttttttttt?tttttaagag?tagatgttgc?atgacattt 49
<210>7
<211>49
<212>DNA
<213〉be selected from the 16SrRNA gene order of streptococcus pneumoniae
<400>7
tttttttttt?tttttttttt?ttttttgtga?gagtggaaag?ttcacactg 49
<210>8
<211>49
<212>DNA
<213〉be selected from the 16SrRNA gene order of coagulase negative staphylococcus/streptococcus aureus
<400>8
tttttttttt?tttttttttt?tttttttcct?acctataaga?ctgggataa 49
<210>9
<211>49
<212>DNA
<213〉be selected from the 16SrRNA gene order of coagulase negative staphylococcus/streptococcus aureus
<400>9
tttttttttt?tttttttttt?ttttttttta?acttcgggaa?accggagct 49
<210>10
<211>49
<212>DNA
<213〉be selected from the 16SrRNA gene order of coagulase negative staphylococcus/streptococcus aureus
<400>10
tttttttttt?tttttttttt?tttttttttg?tcacttatag?atggacccg 49
<210>11
<211>49
<212>DNA
<213〉be selected from the 16SrRNA gene order of Pseudomonas aeruginosa
<400>11
tttttttttt?tttttttttt?ttttttcata?cgtcctgagg?gagaaagtg 49
<210>12
<211>49
<212>DNA
<213〉be selected from the 16SrRNA gene order of Pseudomonas aeruginosa
<400>12
tttttttttt?tttttttttt?ttttgggcag?taagttaata?ccttgctgt 49
<210>13
<211>49
<212>DNA
<213〉be selected from the 16SrRNA gene order of Pseudomonas aeruginosa
<400>13
tttttttttt?tttttttttt?ttttttatga?agggagcttg?ctcctggat 49
<210>14
<211>49
<212>DNA
<213〉be selected from the 16SrRNA gene order of Pseudomonas aeruginosa
<400>14
tttttttttt?tttttttttt?tttttttttc?cgttgggatc?cttgagatc 49
<210>15
<211>49
<212>DNA
<213〉be selected from the 16SrRNA gene order of serratia marcescens
<400>15
tttttttttt?tttttttttt?tttttttacg?ctcatcaatt?gacgttact 49
<210>16
<211>49
<212>DNA
<213〉be selected from the 16SrRNA gene order of serratia marcescens/citrobacter freundii
<400>16
tttttttttt?tttttttttt?ttttttgcac?aggggagctt?gctccctgg 49
<210>17
<211>49
<212>DNA
<213〉be selected from the 16SrRNA gene order of serratia marcescens
<400>17
tttttttttt?tttttttttt?ttttggtggt?gaacttaata?cgttcatca 49
<210>18
<211>49
<212>DNA
<213〉be selected from the 16SrRNA gene order of klebsiella/enterobacteria
<400>18
tttttttttt?tttttttttt?ttttggcgat?aaggttaata?accttgtcg 49
<210>19
<211>49
<212>DNA
<213〉be selected from the 16SrRNA gene order of klebsiella/enterobacteria/citrobacter freundii
<400>19
Tttttttttt?tttttttttt?tttttttagc?acagagagct?tgctctcgg 49
<210>20
<211>49
<212>DNA
<213〉be selected from the 16SrRNA gene order of klebsiella/enterobacteria/serratia marcescens/intestinal bacteria/citrobacter freundii
<400>20
tttttttttt?tttttttttt?tttttcaaag?tgggggacct?tcgggcctc 49
<210>21
<211>49
<212>DNA
<213〉be selected from the 16SrRNA gene order of intestinal bacteria/serratia marcescens/Cray primary/enterobacteria/citrobacter freundii
<400>21
tttttttttt?tttttttttt?tttttttttc?ttgccatcgg?atgtgccca 49
<210>22
<211>49
<212>DNA
<213〉be selected from colibacillary 16SrRNA gene order
<400>22
tttttttttt?tttttttttt?tttagggagt?aaagttaata?cctttgctc 49
<210>23
<211>49
<212>DNA
<213〉be selected from colibacillary 16SrRNA gene order
<400>23
tttttttttt?ttttttttttttttttcagg?aaacagcttg?ctgtttcgc 49
<210>24
<211>49
<212>DNA
<213〉be selected from colibacillary 16SrRNA gene order
<400>24
tttttttttt?tttttttttt?ttttttcagg?aagaagcttg?cttctttgc 49
<210>25
<211>49
<212>DNA
<213〉be selected from the 16SrRNA gene order of faecium
<400>25
tttttttttt?tttttttttt?tttttatgag?agtaactgtt?catcccttg 49
<210>26
<211>49
<212>DNA
<213〉be selected from the 16SrRNA gene order of faecium
<400>26
tttttttttt?tttttttttt?ttttttcaaa?accgcatggt?tttgatttg 49
<210>27
<211>49
<212>DNA
<213〉be selected from the 16SrRNA gene order of enterococcus faecalis
<400>27
tttttttttt?tttttttttt?tttttacgtt?agtaactgaa?cgtcccctg 49
<210>28
<211>49
<212>DNA
<213〉be selected from the 16SrRNA gene order of enterococcus faecalis
<400>28
tttttttttt?tttttttttt?ttttttttat?gccgcatggc?ataagagtg 49
<210>29
<211>49
<212>DNA
<213〉fluorescent probe sequence
<400>29
tttttttttt?tttttttttt?tttttttttt?tttttttttt?ttttttttt 49
<210>30
<211>49
<212>DNA
<213〉negative control probe sequence
<400>30
tttttttttt?tttttttttt?tttttttttt?tttttttttt?ttttttttt 49
<210>31
<211>49
<212>DNA
<213〉positive control probe sequence
<400>31
tttttttttt?tttttttttt?tttttttttt?tactcctacg?ggaggcagc 49
<210>32
<211>20
<212>DNA
<213〉detection probes upstream primer sequence
<400>32
agagtttgat?catggctcag 20
<210>33
<211>20
<212>DNA
<213〉detection probes upstream primer sequence
<400>33
agagtttgat?cctggctcag 20
<210>34
<211>20
<212>DNA
<213〉detection probes downstream primer sequence
<400>34
ccgtcaattc?atttaagttt 20
<210>35
<211>20
<212>DNA
<213〉detection probes downstream primer sequence
<400>35
ccgtcaattc?atttgagttt 20
<210>36
<211>20
<212>DNA
<213〉detection probes downstream primer sequence
<400>36
ccgtcaattc?ctttaagttt 20
<210>37
<211>20
<212>DNA
<213〉detection probes downstream primer sequence
<400>37
ccgtcaattc?ctttgagttt 20

Claims (9)

1. one kind is used for the gene chip that blood pathogen detects, comprise solid phase carrier and the oligonucleotide probe that is fixed on this solid phase carrier, it is characterized in that described oligonucleotide probe comprises the dna fragmentation of choosing from the 16S rRNA gene order of blood pathogen and nuc gene order, described dna fragmentation is shown in SEQ ID NO:1-SEQ ID NO:28.
2. gene chip according to claim 1 is characterized in that described oligonucleotide probe also comprises positive control probe, negative control probe and fluorescent probe.
3. gene chip according to claim 2 is characterized in that described fluorescent probe is shown in SEQ ID NO:29.
4. gene chip according to claim 2 is characterized in that described negative control probe is shown in SEQ ID NO:30.
5. gene chip according to claim 2 is characterized in that described positive control probe is shown in SEQ ID NO:31.
6. according to each described gene chip of claim 1-5, it is characterized in that described blood pathogen is selected from streptococcus aureus, coagulase negative staphylococcus, streptococcus, Pseudomonas aeruginosa, serratia marcescens, klebsiella/enterobacteria, intestinal bacteria, faecium, enterococcus faecalis and citrobacter freundii.
7. one kind is used for the test kit that blood pathogen detects, and it is characterized in that this test kit comprises the described gene chip of claim 1.
8. test kit according to claim 7 is characterized in that described test kit also comprises the primer shown in the SEQ ID NO:32-SEQ ID NO:37.
9. test kit according to claim 8 is characterized in that described test kit also comprises interpretation software and specification sheets that hybridizing box, hybridization solution and Analysis and Identification result use.
CN2007101640062A 2007-10-12 2007-10-12 Gene chip for detecting blood pathogen and reagent kit for detecting Expired - Fee Related CN101407837B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2007101640062A CN101407837B (en) 2007-10-12 2007-10-12 Gene chip for detecting blood pathogen and reagent kit for detecting

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2007101640062A CN101407837B (en) 2007-10-12 2007-10-12 Gene chip for detecting blood pathogen and reagent kit for detecting

Publications (2)

Publication Number Publication Date
CN101407837A CN101407837A (en) 2009-04-15
CN101407837B true CN101407837B (en) 2011-09-21

Family

ID=40571048

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2007101640062A Expired - Fee Related CN101407837B (en) 2007-10-12 2007-10-12 Gene chip for detecting blood pathogen and reagent kit for detecting

Country Status (1)

Country Link
CN (1) CN101407837B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101967510B (en) * 2009-07-28 2012-10-17 天津生物芯片技术有限责任公司 Gene chip and kit for detecting common pathogenic bacteria in food
CN102703577B (en) * 2011-01-28 2014-05-28 珠海出入境检验检疫局检验检疫技术中心 Gene chip and detection method thereof
CN105154439B (en) * 2015-08-04 2019-04-05 南开大学 To Hafnia alvei G5902, G5903, G5904, G5906 special nucleotide sequence
CN105349664A (en) * 2015-11-27 2016-02-24 首都医科大学宣武医院 Gene chip and kit for detecting pathogenic bacteria in cerebrospinal fluid of central nervous system bacterial infester
CN111269995B (en) * 2018-12-04 2023-12-26 深圳华大因源医药科技有限公司 Primer group, kit and detection method for detecting pathogen
CN110093434A (en) * 2019-05-17 2019-08-06 宁波基内生物技术有限公司 A kind of primer and probe composition and kit
CN110241239B (en) * 2019-06-24 2020-04-10 浙江大学 Kit for detecting enterobacter cloacae
CN113502354A (en) * 2021-07-14 2021-10-15 中国医学科学院输血研究所 Pathogen detection primer and probe set for transplanted patient infection, kit and application
CN115992267B (en) * 2022-07-15 2023-11-03 中国医学科学院北京协和医院 Primer group, kit and method for detecting multiple pathogenic bacteria with high flux and high precision

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007039319A2 (en) * 2005-09-29 2007-04-12 Univ Koeln Dna microarray for rapid identification of candida albicans in blood cultures
CN1982472A (en) * 2005-12-16 2007-06-20 天津生物芯片技术有限责任公司 Gene chip for inspecting important intestinal tract peccant germ, its inspecting method and reagent kit

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007039319A2 (en) * 2005-09-29 2007-04-12 Univ Koeln Dna microarray for rapid identification of candida albicans in blood cultures
CN1982472A (en) * 2005-12-16 2007-06-20 天津生物芯片技术有限责任公司 Gene chip for inspecting important intestinal tract peccant germ, its inspecting method and reagent kit

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Small J,et al.《Direct detection of 16S rRNA in soil extracts by using olygonucleotide microarrays》.《Appl Environ Microbiol》.2001,第67卷(第10期),4708-16. *

Also Published As

Publication number Publication date
CN101407837A (en) 2009-04-15

Similar Documents

Publication Publication Date Title
CN101407837B (en) Gene chip for detecting blood pathogen and reagent kit for detecting
Call Challenges and opportunities for pathogen detection using DNA microarrays
Severgnini et al. Advances in DNA microarray technology for the detection of foodborne pathogens
CN104619860B (en) Method for detecting and identifying enterohemorrhagic escherichia coli
Koeleman et al. Comparison of amplified ribosomal DNA restriction analysis, random amplified polymorphic DNA analysis, and amplified fragment length polymorphism fingerprinting for identification of Acinetobacter genomic species and typing of Acinetobacter baumannii
JP2976406B2 (en) Nucleic acid probe
EP2082063B1 (en) Multitag sequencing and ecogenomics analysis
Devriese et al. Differentiation and identification of Enterococcus durans, E. hirae and E. villorum
US20090035767A1 (en) Primer for bacterium genome amplification reaction
EP3004386A1 (en) Microbial markers and uses therefor
EP2363497A2 (en) Method for the detection and/or identification of a microorganism
WO2008147879A1 (en) Automated method and device for dna isolation, sequence determination, and identification
US20110256535A1 (en) Optimized oligonucleotides and methods of using same for the detection, isolation, amplification, quantification, monitoring, screening and sequencing of clostridium difficile genes encoding toxin b, and/or toxin a and/or binary toxin
CN113136443B (en) Nucleic acid detection method for rapidly identifying bacillus cereus and bacillus thuringiensis
Tung et al. Array-based identification of species of the genera Abiotrophia, Enterococcus, Granulicatella, and Streptococcus
CN105112510A (en) Gene chip for typing mycobacteria and application method thereof
CN108642192A (en) A kind of method of haemophilus parasuis multidigit point sequence molecule parting
CN110846424B (en) Rapid inspection and quarantine method for entry and exit port microorganisms
CN101864490A (en) Bacteriaemia aspartame assay kit and assay method thereof
AU776138B2 (en) Detection of mycobacterium avium subspecies
CN105256041A (en) Specific nucleotide for aeromonas hydrophila O44, O24, O25 and O28 and application thereof
Somer et al. Amplified intergenic locus polymorphism as a basis for bacterial typing of Listeria spp. and Escherichia coli
Xu et al. Application of Next Generation Sequencing in identifying different pathogens
Cassone et al. Bacterial DNA microarrays for clinical microbiology: the early logarithmic phase
CN106480183A (en) Pyrosequencing detection mycobacterium tuberculosis kanamycin, amikacin, the method for capreomycin drug resistance

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20110921

Termination date: 20121012